Home - Products - JAK/STAT Signaling - STAT - BTA-9881

BTA-9881

CAS No. 1646857-24-0

BTA-9881( —— )

Catalog No. M34195 CAS No. 1646857-24-0

BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	122	Get Quote
5MG	372	Get Quote
10MG	635	Get Quote
25MG	1343	Get Quote
50MG	1822	Get Quote
100MG	2403	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BTA-9881
Note

Research use only, not for human use.
Brief Description

BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Description

BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

JAK/STAT Signaling
Target

STAT
Recptor

RSV
Research Area

——
Indication

——

Chemical Information

CAS Number

1646857-24-0
Formula Weight

390.82
Molecular Formula

C21H15ClN4O2
Purity

>98% (HPLC)
Solubility

——
SMILES

C(=O)(N1[C@]2(C=3C(C(=O)N2CC1)=CC=NC3)C4=CC=C(Cl)C=C4)C=5C=CC=NC5
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CPA-7

A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.
UC-514321

UC-514321 is a more effective analog of NSC-370284 that directly binds to STAT3/5.
LLL-12

A nonpeptide, cell-permeable STAT3 inhibitor that binds directly to the pTyr705 binding site of the STAT3 monomer.

Sign In Join Free